Malignant Glioma In Vitro Models: On the Utilization of Stem-like Cells

Title:Malignant Glioma In Vitro Models: On the Utilization of Stem-like Cells

Volume: 17 Issue: 3

Author(s): Rutger K. Balvers, Clemens M.F. Dirven, Sieger Leenstra and Martine L.M. Lamfers

Affiliation:

Keywords: Glioblastoma, in vitro models, GSC, tumor profiling, TCGA, cell culture, tumor heterogeneity.

Abstract: Recent publications on the molecular characterization of malignant glioma have had profound impact on the appreciation of tumoral heterogeneity within and between patients. Both these phenomena are implicated in the variability in clinical outcome between patients, as well as the inevitable recurrence of these tumors after conventional treatment. The advent of selective cell culture protocols for the propagation of patient-derived glioma stem-like cells (GSCs) provides researchers the ability to selectively study the cells that could be at the root of tumor proliferation and resistance to therapy. As these techniques are widely applied in contemporary studies and becoming the preferred in vitro model, molecular characterization of GSCs is considered pivotal for the identification and advancement of novel therapies for this devastating disease.

Cite this article as:

Balvers K. Rutger, Dirven M.F. Clemens, Leenstra Sieger and Lamfers L.M. Martine, Malignant Glioma In Vitro Models: On the Utilization of Stem-like Cells, Current Cancer Drug Targets 2017; 17 (3) . https://dx.doi.org/10.2174/1568009616666160813191809